Skip to main content
SpringerLink
Log in

Risk Factors in Proliferative Vitreoretinopathy

  • Chapter
Vitreo-retinal Surgery

Part of the book series: Essentials in Ophthalmology ((ESSENTIALS))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 159.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 209.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Algvere PV, Hallnas K, Dafgard E, et al (1990) Pan-retinal photocoagulation aggravates experimental proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 228:461–466

    Article  PubMed  CAS  Google Scholar 

  2. Asaria RH, Kon CH, Bunce C, et al (2001) Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy: Results from a randomized, do uble-blind, controlled clinical trial. Ophthalmology 108:1179–1183

    Article  PubMed  CAS  Google Scholar 

  3. Asaria RH, Kon CH, Bunce C, et al (2001) How to predict proliferative vitreoretinopathy: a prospective study. Ophthalmology 108:1184–1186

    Article  PubMed  CAS  Google Scholar 

  4. Barile GR, Chang SS, Park LS, et al (1999) Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy. Curr Eye Res 19:219–227

    Article  PubMed  CAS  Google Scholar 

  5. Baudouin C, Fredj-Reygrobellet D, Brignole F, et al (1993) Growth factors in vitreous and subretinal fluid cells from patients with proliferative vitreoretinopathy. Ophthalmic Res 25:52–59

    PubMed  CAS  Google Scholar 

  6. Bonnet M (1984) Clinical factors predisposing to massive proliferative vitreoretinopathy in rhegmatogenous retinal detachment. Ophthalmologica 188:148–152

    Article  PubMed  CAS  Google Scholar 

  7. Bonnet M (1988) The development of severe proliferative vitreoretinopathy after retinal detachment surgery. Grade B: a determining risk factor. Graefes Arch Clin Exp Ophthalmol 226:201–205

    Article  PubMed  CAS  Google Scholar 

  8. Bonnet M, Fleury J, Guenoun S, et al (1996) Cryopexy in primary rhegmatogenous retinal detachment: a risk factor for postoperative proliferative vitreoretinopathy? Graefes Arch Clin Exp Ophthalmol 234:739–743

    Article  PubMed  CAS  Google Scholar 

  9. Briggs MC, Grierson I, Hiscott P, et al (2000) Active scatter factor (HGF/SF) in proliferative vitreoretinal disease. Invest Ophthalmol Vis Sci 41:3085–3094

    PubMed  CAS  Google Scholar 

  10. Campochiaro PA, Kaden IH, Vidaurri-Leal J, et al (1985) Cryotherapy enhances intravitreal dispersion of viable retinal pigment epithelial cells. Arch Ophthalmol 103:434–436

    PubMed  CAS  Google Scholar 

  11. Campochiaro PA, Sugg R, Grotendorst G, et al (1989) Retinal pigment epithelial cells produce PDGF-like proteins and secrete them into their media. Exp Eye Res 49:217–227

    Article  PubMed  CAS  Google Scholar 

  12. Capeans C, Lorenzo J, Santos L, et al (1998) Comparative study of incomplete posterior vitreous detachment as a risk factor for proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 236:481–485

    Article  PubMed  CAS  Google Scholar 

  13. Cardillo JA, Stout JT, LaBree L, et al (1997) Posttraumatic proliferative vitreoretinopathy. iThe epidemiologic profile, onset, risk factors, and visual outcome. Ophthalmology 104:1166–1173

    PubMed  CAS  Google Scholar 

  14. Cassidy L, Barry P, Shaw C, et al (1998) Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders. Br J Ophthalmol 82:181–185

    PubMed  CAS  Google Scholar 

  15. Chignell AH, Fison LG, Davies EW, et al (1973) Failure in retinal detachment surgery. Br J Ophthalmol 57:525–530

    PubMed  CAS  Google Scholar 

  16. Connor TB Jr, Roberts AB, Sporn MB, et al (1989) Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest 83:1661–1666

    Article  PubMed  CAS  Google Scholar 

  17. Constable IJ (1975) Pathology of vitreous membranes and the effect of haemorrhage and new vessels on the vitreous. Trans Ophthalmol Soc U K 95:382–386

    PubMed  CAS  Google Scholar 

  18. Cowley M, Conway BP, Campochiaro PA, et al (1989) Clinical risk factors for proliferative vitreoretinopathy. Arch Ophthalmol 107:1147–1151

    PubMed  CAS  Google Scholar 

  19. Duquesne N, Bonnet M, Adeleine P (1996) Preoperative vitreous hemorrhage associated with rhegmatogenous retinal detachment: a risk factor for postoperative proliferative vitreoretinopathy? Graefes Arch Clin Exp Ophthalmol 234:677–682

    Article  PubMed  CAS  Google Scholar 

  20. Ehrenberg M, Thresher RJ, Machemer R (1984) Vitreous hemorrhage nontoxic to retina as a stimulator of glial and fibrous proliferation. Am J Ophthalmol 97:611–626

    PubMed  CAS  Google Scholar 

  21. El Ghrably IA, Dua HS, Orr GM, et al (1999) Detection of cytokine mRNA production in infiltrating cells in proliferative vitreoretinopathy using reverse transcription polymerase chain reaction. Br J Ophthalmol 83:1296–1299

    PubMed  Google Scholar 

  22. El Ghrably IA, Dua HS, Orr GM, et al (2001) Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy. Br J Ophthalmol 85:461–470

    Article  PubMed  Google Scholar 

  23. Elner SG, Elner VM, Jaffe GJ, et al (1995) Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Curr Eye Res 14:1045–1053

    PubMed  CAS  Google Scholar 

  24. Gilbert C, Hiscott P, Unger W, et al (1988) Inflammation and the formation of epiretinal membranes. Eye 2Suppl:S140–S156

    PubMed  Google Scholar 

  25. Girard P, Mimoun G, Karpouzas I, et al (1994) Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery. Retina 14:417–424

    PubMed  CAS  Google Scholar 

  26. Glaser BM, Vidaurri-Leal J, Michels RG, et al (1993) Cryotherapy during surgery for giant retinal tears and intravitreal dispersion of viable retinal pigment epithelial cells. Ophthalmology 100:466–470

    PubMed  CAS  Google Scholar 

  27. Grierson I, Heathcote L, Hiscott P, et al (2000) Hepatocyte growth factor/scatter factor in the eye. Prog Retin Eye Res 19:779–802

    Article  PubMed  CAS  Google Scholar 

  28. Grizzard WS, Hilton GF, Hammer ME, et al (1994) A multivariate analysis of anatomic success of retinal detachments treated with scleral buckling. Graefes Arch Clin Exp Ophthalmol 232:1–7

    Article  PubMed  CAS  Google Scholar 

  29. Grizzard WS, Hilton GF, Hammer ME, et al (1995) Pneumatic retinopexy failures. Cause, prevention, timing, and management. Ophthalmology 102:929–936

    PubMed  CAS  Google Scholar 

  30. Hinton DR, He S, Jin ML, et al (2002) Novel growth factors involved in the pathogenesis of proliferative vitreoretinopathy. Eye 16:422–428

    Article  PubMed  CAS  Google Scholar 

  31. Ie D, Gordon LW, Glaser BM, et al (1994) Trans-forming growth factor-beta 2 levels increase following retinal laser photocoagulation. Curr Eye Res 13:743–746

    PubMed  CAS  Google Scholar 

  32. Jin M, He S, Worpel V, et al (2000) Promotion of adhesion and migration of RPE cells to provisional extracellular matrices by TNF-alpha. Invest Ophthalmol Vis Sci 41:4324–4332

    PubMed  CAS  Google Scholar 

  33. Kauffmann DJ, van Meurs JC, Mertens DA, et al (1994) Cytokines in vitreous humor: interleukin-6 is elevated in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 35:900–906

    PubMed  CAS  Google Scholar 

  34. Kirchhof B, Sorgente N (1989) Pathogenesis of proliferative vitreoretinopathy. Modulation of retinal pigment epithelial cell functions by vitreous and macrophages. Dev Ophthalmol 16:1–53

    PubMed  CAS  Google Scholar 

  35. Kon CH, Occleston NL, Charteris DG, et al (1998) A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 39:1524–1529

    PubMed  CAS  Google Scholar 

  36. Kon CH, Occleston NL, Aylward GW, et al (1999) Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study. Invest Ophthalmol Vis Sci 40:705–712

    PubMed  CAS  Google Scholar 

  37. Kon CH, Asaria RH, Occleston NL, et al (2000) Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study. Br J Ophthalmol 84:506–511

    Article  PubMed  CAS  Google Scholar 

  38. La Heij EC, van de Waarenburg MP, Blaauwgeers HG, et al (2002) Basic fibroblast growth factor, glutamine synthetase, and interleukin-6 in vitreous fluid from eyes with retinal detachment complicated by proliferative vitreoretinopathy. Am J Ophthalmol 134:367–375

    Article  PubMed  Google Scholar 

  39. Lambrou FH, Burke JM, Aaberg TM (1987) Effect of silicone oil on experimental traction retinal detachment. Arch Ophthalmol 105:1269–1272

    PubMed  CAS  Google Scholar 

  40. Limb GA, Chignell AH (1999) Vitreous levels of intercellular adhesion molecule 1 (ICAM-1) as a risk indicator of proliferative vitreoretinopathy. Br J Ophthalmol 83:953–956

    PubMed  CAS  Google Scholar 

  41. Limb GA, Earley O, Jones SE, et al (1994) Expression of mRNA coding for TNF alpha, IL-1 beta and IL-6 by cells infiltrating retinal membranes. Graefes Arch Clin Exp Ophthalmol 232:646–651

    Article  PubMed  CAS  Google Scholar 

  42. Lincoff H, Kreissig I (1971) The mechanism of the cryosurgical adhesion. IV. Electron microscopy. Am J Ophthalmol 71:674–689

    PubMed  CAS  Google Scholar 

  43. Machemer R, Allen AW (1976) Retinal tears 180 degrees and greater. Management with vitrectomy and intravitreal gas. Arch Ophthalmol 94:1340–1346

    PubMed  CAS  Google Scholar 

  44. Malbran E, Dodds RA, Hulsbus R, et al (1990) Retinal break type and proliferative vitreoretinopathy in nontraumatic retinal detachment. Graefes Arch Clin Exp Ophthalmol 228:423–425

    Article  PubMed  CAS  Google Scholar 

  45. Malecaze F, Mathis A, Arne JL, et al (2004) Localization of acidic fibroblast growth factor in proliferative vitreoretinopathy membranes. Curr Eye Res 10:719–729

    Google Scholar 

  46. Miller B, Miller H, Ryan SJ (1986) Experimental epiretinal proliferation induced by intravitreal red blood cells. Am J Ophthalmol 102:188–195

    PubMed  CAS  Google Scholar 

  47. Miyake K (1985) Blood retinal barriers in eyes with long-standing aphakic eyes after extra-and intracapsular lens extraction. Graefes Arch Clin Exp Ophthalmol 222:232–233

    Article  Google Scholar 

  48. Nagasaki H, Ideta H, Mochizuki M, et al (1993) A case-control study of risk factors for proliferative vitreoretinopathy in aphakia. Jpn J Ophthalmol 37:187–191

    PubMed  CAS  Google Scholar 

  49. Nagasaki H, Ideta H, Uemura A, et al (1991) Comparative study of clinical factors that predispose patients to proliferative vitreoretinopathy in aphakia. Retina 11:204–207

    PubMed  CAS  Google Scholar 

  50. Nagasaki H, Shinagawa K, Mochizuki M (1998) Risk factors for proliferative vitreoretinopathy. Prog Retin Eye Res 17:77–98

    Article  PubMed  CAS  Google Scholar 

  51. Oguchi C (1912) Über die Wirkung von Blutinjektionen in den Glaskorper nebst Bemerkungen über die sug. Retinitis proliferans. Graefes Arch Clin Exp Ophthalmol 84:446

    Google Scholar 

  52. Pena RA, Jerdan JA, Glaser BM (1994) Effects of TGF-beta and TGF-beta neutralizing antibodies on fibroblast-induced collagen gel contraction: implications for proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 35:2804–2808

    PubMed  CAS  Google Scholar 

  53. Pfeffer BA, Flanders KC, Guerin CJ, et al (1994) Transforming growth factor beta 2 is the predominant isoform in the neural retina, retinal pigment epithelium-choroid and vitreous of the monkey eye. Exp Eye Res 59:323–333

    Article  PubMed  CAS  Google Scholar 

  54. Ross R, Raines EW, Bowen-Pope DF (1986) The biology of platelet-derived growth factor. Cell 46:155–169

    Article  PubMed  CAS  Google Scholar 

  55. Shimada (1982) Basic study on pars plana vitrectomy, part 2. Electron-microscopic study of the effect on the blood-ocular barrier of the monkey eyes using horseradish peroxidase tracer technique. Nippon Ganka Gakkai Zasshi 86:669–686

    PubMed  CAS  Google Scholar 

  56. Tolentino FI, Schepens CL, Freeman HM (1967) Massive preretinal retraction. A biomicroscopic study. Arch Ophthalmol 78:16–22

    PubMed  CAS  Google Scholar 

  57. Webster L, Chignell AH, Limb GA (1999) Predominance of MMP-1 and MMP-2 in epiretinal and subretinal membranes of proliferative vitreoretinopathy. Exp Eye Res 68:91–98

    Article  PubMed  CAS  Google Scholar 

  58. Yanyali A, Bonnet M (1996) Risk factors of postoperative proliferative vitreoretinopathy in giant tears. J Fr Ophtalmol 19:175–180

    PubMed  CAS  Google Scholar 

  59. Yeo JH, Sadeghi J, Campochiaro PA, et al (1986) Intravitreous fibronectin and platelet-derived growth factor.New model for traction retinal detachment. Arch Ophthalmol 104:417–421

    PubMed  CAS  Google Scholar 

  60. Yoshino Y, Ideta H, Nagasaki H, et al (1989) Comparative study of clinical factors predisposing patients to proliferative vitreoretinopathy. Retina 9:97–100

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 6 Offington Gardens, Worthing West Sussex, BN14 9AT, UK

    Chee Hing Kon MD & Paris Tranos MD

  2. Moorfields Eye Hospital, City Road, London, EC1V 2PD, UK

    George William Aylward MD (Consultant Ophthalmologist)

Authors
  1. Chee Hing Kon MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paris Tranos MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. George William Aylward MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Ophthalmology, University of Cologne, Joseph-Stelzmann-Straße 9, 50931, Cologne, Germany

    Bernd Kirchhof MD (Professor of Ophthalmology) (Professor of Ophthalmology)

  2. St. Paul’s Eye Unit, Royal Liverpool University Hospital, Prescot Street, Liverpool, L7 8XP, UK

    David Wong MD (Consultant Ophthalmologist) (Consultant Ophthalmologist)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kon, C.H., Tranos, P., Aylward, G.W. (2005). Risk Factors in Proliferative Vitreoretinopathy. In: Kirchhof, B., Wong, D. (eds) Vitreo-retinal Surgery. Essentials in Ophthalmology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27152-X_8

Download citation

  • DOI: https://doi.org/10.1007/3-540-27152-X_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-20044-4

  • Online ISBN: 978-3-540-27152-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation